Abstract
INTRODUCTION: Guidelines for regular diabetic retinopathy (DR) have been published in Malaysia, and screening for DR were strengthened in the year 2000 with the provision of fundus cameras in selected Ministry of Health (MOH) health clinics throughout Malaysia. This study aims to describe the coverage of DR screening among type-2 diabetes patients receiving treatment at MOH health clinics, and factors influencing the coverage. METHODS: Data on rates of DR screening was extracted from the National Diabetes Registry for year 2015 to 2018. Comments on the screening coverage were elicited from each State Health Department using a standardised format. RESULTS: Overall, DR screening coverage in Malaysia was low at 55.9% for 2018, but with an increasing trend from 50.0% in 2015. There are huge variations between states, however most states showed an increasing trend. For 2018, Putrajaya showed the highest coverage, while Pahang showed the lowest. For most states, there are huge variations of screening coverage between districts as well. Several factors were identified to contribute to an increasing trend of coverage within the domains of healthcare facilities and systems, healthcare provider factors and patient-related factors. Likewise, several factors were also identified that negatively influenced DR screening coverage. DISCUSSION: This study highlighted the huge variations of DR screening between states and districts over the time period of 2015 to 2018. Improving and narrowing the variations in DR screening coverage would require addressing the multiple factors, and solutions have to be customised for each specific setting.
Links
BibTeX (Download)
@proceedings{APCPH-2019-190,
title = {Improving Diabetic Retinopathy Screening Coverage in Malaysia},
author = {Feisul Idzwan Mustapha and Arunah Chandran},
year = {2019},
date = {2019-07-22},
urldate = {2019-07-22},
journal = {6th Asia-Pacific Conference on Public Health 2019 Proceedings},
issue = {6},
abstract = {INTRODUCTION: Guidelines for regular diabetic retinopathy (DR) have been published in Malaysia, and screening for DR were strengthened in the year 2000 with the provision of fundus cameras in selected Ministry of Health (MOH) health clinics throughout Malaysia. This study aims to describe the coverage of DR screening among type-2 diabetes patients receiving treatment at MOH health clinics, and factors influencing the coverage. METHODS: Data on rates of DR screening was extracted from the National Diabetes Registry for year 2015 to 2018. Comments on the screening coverage were elicited from each State Health Department using a standardised format. RESULTS: Overall, DR screening coverage in Malaysia was low at 55.9% for 2018, but with an increasing trend from 50.0% in 2015. There are huge variations between states, however most states showed an increasing trend. For 2018, Putrajaya showed the highest coverage, while Pahang showed the lowest. For most states, there are huge variations of screening coverage between districts as well. Several factors were identified to contribute to an increasing trend of coverage within the domains of healthcare facilities and systems, healthcare provider factors and patient-related factors. Likewise, several factors were also identified that negatively influenced DR screening coverage. DISCUSSION: This study highlighted the huge variations of DR screening between states and districts over the time period of 2015 to 2018. Improving and narrowing the variations in DR screening coverage would require addressing the multiple factors, and solutions have to be customised for each specific setting.},
note = {Type: POSTER PRESENTATION; Organisation: Disease Control Division, Ministry of Health Malaysia},
keywords = {diabetes, fundus screening, primary care, retinopathy},
pubstate = {published},
tppubtype = {proceedings}
}